AAAAAA
Results:
1-18
|
Results: 18
Authors:
De Vita, F
Romano, C
Orditura, M
Galizia, G
Martinelli, E
Lieto, E
Catalano, G
Citation: F. De Vita et al., Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator, J INTERF CY, 21(1), 2001, pp. 45-52
Authors:
Ianniello, GP
Orditura, M
Rossi, A
De Vita, F
Maiorino, L
Carrozza, F
Manzione, L
Catalano, G
Citation: Gp. Ianniello et al., Gemcitabine plus epirubicin in advanced pancreatic cancer: A phase II multicenter trial, ONCOL REP, 8(5), 2001, pp. 1111-1115
Authors:
Ribuffo, D
Cavalieri, L
De Vita, F
Massa, R
Prosperi, D
Tuccimei, M
Scuderi, N
Citation: D. Ribuffo et al., Current role of immunoscintigraphy in malignant melanoma follow-up. A study of 114 patients, J EXP CL C, 20(1), 2001, pp. 11-15
Authors:
De Vita, F
Orditura, M
Infusino, S
Martinelli, E
Merola, MC
Morgillo, F
Cosenza, A
Di Martino, N
Del Genio, A
Catalano, G
Citation: F. De Vita et al., Preoperative chemo-radiotherapy for carcinoma of the esophagus, TUMORI, 87(4), 2001, pp. S24-S27
Authors:
De Vita, F
Orditura, M
Galizia, G
Romano, C
Lieto, E
Iodice, P
Tuccillo, C
Catalano, G
Citation: F. De Vita et al., Serum interleukin-10 is an independent prognostic factor in advanced solidtumors, ONCOL REP, 7(2), 2000, pp. 357-361
Authors:
Orditura, M
De Vita, F
Belli, A
Ciaramella, F
Musico, M
Ferrigno, A
Formato, R
Abbate, G
Diadema, MR
Catalano, G
Citation: M. Orditura et al., Efficacy and safety profile of amifostine in the preoperative combined therapy of esophageal cancer patients, ONCOL REP, 7(2), 2000, pp. 397-400
Authors:
Lorusso, V
Palmieri, G
Bianco, AR
Abate, G
Catalano, G
De Vita, F
Dammacco, F
Lauta, VM
Lucarelli, G
Polimeno, G
Mantovani, G
D'Aprile, M
Marzullo, F
De Lena, M
Citation: V. Lorusso et al., CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group, INT J ONCOL, 16(1), 2000, pp. 149-154
Authors:
Comella, P
De Vita, F
De Lucia, L
Casaretti, R
Avallone, A
Orditura, M
Rivellini, F
Palmeri, S
Catalano, G
Comella, G
Citation: P. Comella et al., Oxaliplatin and raltitrexed combined with leucovorin-modulated 5-fluorouracil i.v. bolus every two weeks: A dose finding study in advanced previouslytreated colorectal carcinoma, ANN ONCOL, 11(4), 2000, pp. 461-468
Authors:
Comella, P
De Vita, F
Mancarella, S
De Lucia, L
Biglietto, M
Casaretti, R
Farris, A
Ianniello, GP
Lorusso, V
Avallone, A
Carteni, G
Leo, S
Catalano, G
De Lena, M
Comella, G
Citation: P. Comella et al., Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: A Southern Italy Cooperative Oncology Group phase II-III randomized trial, ANN ONCOL, 11(10), 2000, pp. 1323-1333
Authors:
Orditura, M
Romano, C
De Vita, F
Galizia, G
Lieto, E
Infusino, S
De Cataldis, G
Catalano, G
Citation: M. Orditura et al., Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival, CANCER IMMU, 49(10), 2000, pp. 530-536
Authors:
Lorusso, V
Manzione, L
De Vita, F
Antimi, M
Selvaggi, FP
De Lena, M
Citation: V. Lorusso et al., Gemcitabine plus cisplatin for advanced transitional cell carcinoma of theurinary tract: A phase II multicenter trial, J UROL, 164(1), 2000, pp. 53-56
Authors:
De Vita, F
Orditura, M
Galizia, G
Romano, C
Roscigno, A
Lieto, E
Catalano, G
Citation: F. De Vita et al., Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients, CHEST, 117(2), 2000, pp. 365-373
Authors:
Caponigro, F
Avallone, A
McLeod, H
Carteni, G
De Vita, F
Casaretti, R
Morsman, J
Blackie, R
Budillon, A
De Lucia, L
Gravina, A
Catalano, G
Comella, P
Comella, G
Citation: F. Caponigro et al., Phase I and pharmacokinetic study of Tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer, CLIN CANC R, 5(12), 1999, pp. 3948-3955
Authors:
Orditura, M
De Vita, F
Roscigno, A
Infusino, S
Auriemma, A
Iodice, P
Ciaramella, F
Abbate, G
Catalano, G
Citation: M. Orditura et al., Amifostine: A selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review), ONCOL REP, 6(6), 1999, pp. 1357-1362
Authors:
Comella, P
Casaretti, R
De Vita, F
Avallone, A
Orditura, M
Petrillo, A
Gravina, A
Faranda, A
Comis, S
Comella, G
Catalano, G
Citation: P. Comella et al., Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma:A phase I study of the Southern Italy Cooperative Oncology Group, ANN ONCOL, 10(8), 1999, pp. 915-921
Authors:
De Vita, F
Orditura, M
Auriemma, A
Infusino, S
Catalano, G
Citation: F. De Vita et al., A pilot study of adjuvant chemotherapy with double modulation of 5-Fluorouracil by Methotrexate and Leucovorin in gastric cancer patients, PANMIN MED, 41(1), 1999, pp. 35-38
Authors:
De Vita, F
Orditura, M
Galizia, G
Romano, C
Infusino, S
Auriemma, A
Lieto, E
Catalano, G
Citation: F. De Vita et al., Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies, CANCER, 86(10), 1999, pp. 1936-1943
Authors:
De Vita, F
Orditura, M
Auriemma, A
Infusino, S
Catalano, G
Citation: F. De Vita et al., Serum concentrations of proinflammatory cytokines in advanced non small cell lung cancer patients, J EXP CL C, 17(4), 1998, pp. 413-417
Risultati:
1-18
|